HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 14851909, compound → HCID 14851920, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 14851909 | HCID 14851909 | — |
| Reactant | HCID 14894666 | HCID 14894666 | — |
| Product | HCID 14851920 | HCID 14851920 | — |
Reaction Steps
The title compound was prepared by coupling 6-(2-fluorophenyl)-1-(trifluoromethyl)-8-iodo-4H-[1,2,4]triazolo [4,3-a][1,4]benzodiazepine with 3,4-dihydro-1-(2-propynyl)-2(1H)-quinolinone under the conditions used in Example 37. The product was purified by chromatoqraphy over the 50-fold amount of silica gel using 5% (v/v) of ethanol in methylene chloride. The clean fractions were combined and evaporated and the residue was crystallized from ethyl acetate to yield colorless crystals of 1-{3-[6-(2-fluorophenyl)-1-(trifluoromethyl)-4H-[1,2,4]triazolo[4,3-a][4,1]benzodiazepin-8-yl]-2-propynyl}-3,4-dihydro-2(1H)-quinolinone with m.p. 193°-196°.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US04959361 |
| Source dataset | uspto-grants-1990_09 |
| ORD ID | ord-576e9e54e20a4270b792c285e6e06fc6 |
| Source note | uspto-grants-1990_09 |